SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
mBank S.A. (BREJY) trades at a trailing P/E of 1.1, forward P/E of 1.0. Trailing earnings yield is 90.09%, forward earnings yield 104.17%. PEG 0.06 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (1.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.06); earnings yield beats bond yields (90.09%).
- Forward P/E 1.0 (down from trailing 1.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.06 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 90.09% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 104.17% as earnings recover.
Overall SharesGrow Score: 76/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BREJY
Valuation Multiples
P/E (TTM)1.1
Forward P/E1.0
PEG Ratio0.06
Forward PEG0.06
P/B Ratio0.00
P/S Ratio0.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.99
Forward EPS (Est.)$4.61
Book Value / Share$0.00
Revenue / Share$16.40
FCF / Share$0.00
Yields & Fair Value
Earnings Yield90.09%
Forward Earnings Yield104.17%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.07 |
$4.34B |
$1.22B |
28.1% |
| 2017 |
$0.06 |
$4.68B |
$1.09B |
23.3% |
| 2018 |
$0.08 |
$4.77B |
$1.32B |
27.6% |
| 2019 |
$0.06 |
$5.59B |
$1.01B |
18.1% |
| 2020 |
$0.01 |
$5.37B |
$103.83M |
1.9% |
| 2021 |
$-0.07 |
$6.3B |
$-1.18B |
-18.7% |
| 2022 |
$-0.04 |
$8.11B |
$-702.53M |
-8.7% |
| 2023 |
$0.00 |
$9.99B |
$24.05M |
0.2% |
| 2024 |
$0.13 |
$12B |
$2.24B |
18.7% |
| 2025 |
$3.99 |
$13.96B |
$3.39B |
24.3% |
